Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001512830 | SCV001720317 | benign | X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821814 | SCV002071977 | likely benign | not specified | 2021-11-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002564314 | SCV003736399 | uncertain significance | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | The c.83G>A (p.G28E) alteration is located in exon 1 (coding exon 1) of the MAGT1 gene. This alteration results from a G to A substitution at nucleotide position 83, causing the glycine (G) at amino acid position 28 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003438852 | SCV004165901 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MAGT1: BP4, BS2 |